The present disclosure relates generally to compounds that bind to Acetyl-CoA Carboxylase (ACC) and act as inhibitors of ACC. The disclosure further relates to the use of the compounds for the preparation of a medicament for the treatment of diseases and/or conditions through binding of ACC, including liver diseases such as non-alcoholic fatty liver disase (NAFLD) and non-alcoholic steatohepatitis (NASH).
本公开涉及一般与结合
乙酰辅酶A羧化酶(ACC)并作为ACC的
抑制剂的化合物有关。此外,本公开还涉及利用这些化合物制备药物以治疗通过结合ACC引起的疾病和/或状况,包括非
酒精性脂肪肝病(NAFLD)和非
酒精性脂肪性肝炎(NASH)等肝病。